9
Views
71
CrossRef citations to date
0
Altmetric
Original Articles

A Biochemical Concept of Mental Disease

Pages 111-118 | Published online: 18 Apr 2016

REFERENCES

  • De Ropp, R. S.: Drugs and the Mind. New York, St. Martin's Press, Inc., 1957.
  • Thudichum, J. W. L.: A Treatise on the Chemical Constitution of the Brain. London, Ballière, Tindall and Cox, 1884.
  • Rapport, M. M., Green, A. A. and Pace, I. H.: Crystalline serotonin. Science 108: 329, 1948.
  • Pace, I. H.: Serotonin (5-hydroxytryptamine); the last four years. Physiol. Rev. 38: 277, 1958.
  • Twarog, B. M. and Pace, I. H.: Serotonin content of some mammalian tissues and urine and method for its determination. Am. J. Physiol. 175: 157, 1953.
  • Brodie, B. B. and Shore, P. A.: A concept for a role of serotonin and norepinephrine as chemical mediators in the brain. Ann. New York Acad. Sc. 66: 631, 1957.
  • Woolley, D. W. and Shaw, E.: A biochemical and pharmacological suggestion about certain mental disorders. (Abstr.) Science 119: 587, 1954.
  • Gaddum, J. H.: Ciba Foundation Symposium on Hypertension. Boston, Little, Brown and Company, 1954.
  • Kety, S. S.: Biochemical theories of schizophrenia. Part I. Science 129: 1528, 1959.
  • Udenfriend, S., Titus, E., Weissbach, H. and Peterson, R. E.: Biogenesis And Metabolism Of 5-Hydroxyindole Compounds. J. Biol. Chem. 219: 335, 1956.
  • Erspamer, V.: Observations on the fate of indolalkylamines in an organism. J. Physiol. 127: 118, 1955.
  • McIsaac, W. M. and Page, I. H.: The metabolism of serotonin (5-hydroxytryptamine). J. Biol. Chem. 234: 858, 1959.
  • Wasson, V. P. and Wasson, R. G.: Mushrooms, Russia and History. New York, Pantheon Books, Inc., 1957.
  • Hofmann, A., Heim, R., Brack, A. and Kobel, H.: Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz Psilocybe mexicana Heim. Experientia 14: 107, 1958.
  • Gessner, P. K., Khairallah, P. A., McIsaac, W. M. and Pace, I. H.: The relationship between the metabolic fate and pharmacological actions of serotonin, bufotenine and psilocybin. J. Pharmacol. & Exper. Therap. 130: 126, 1960.
  • Gessner, P. K., McIsaac, W. M. and Page, I. H.: The pharmacological actions of some methoxyindole-alkylamines. Nature, London. (In press.)
  • Lerner, A. B., Case, J. D. and Takahashi, Y.: Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J. Biol. Chem. 235: 1992, 1960.
  • Lerner, A. B.: Mechanism of hormone action. Nature, London 184: 674, 1959.
  • McIsaac, W. M., Kveder, S. and Page, I. H.: The metabolism of 5-(β-14C) methoxytryptamine. Biochem. J. 76: 30p, 1960.
  • Kveder, S., McIsaac, W. M. and Page, I. H.: The metabolism of N-acetyl-5-(β-14C) methoxytryptamine. Ibid.,19 p. 28 p.
  • Kopin, I. J., Pare, C. M. C., Axelrod, J. and Weissbach, H.: 6-Hydroxylation, the major metabolic pathway for melatonin. Biochim. et biophys. acta 40: 377, 1960.
  • Udenfriend, S., Witkop, B., Redfield, B. G. and Weissbach, H.: Studies with reversible inhibitors of monoamine oxidase: Harmaline and related compounds. Biochem. Pharmacol. 1: 160, 1958.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.